RxDoctor Payments Data

Barbara Kupka, DO

Family Medicine · Camilla, GANPI 1124090030

Payments from drug & device makers

$3,327in general payments, 2019–2025

Across 202 payments — averaging $16.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$890
  • Boehringer Ingelheim$376
  • Novo Nordisk$368
  • Johnson & Johnson$332
  • Dexcom, Inc.$317
  • Merck$158
  • plus $887 from 15 others

What the payments were for

  • Food & beverage$3,327100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,327 in reported general payments places this provider in the 75th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$56,985
Medicare patients
135
Services billed
1,052

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate65$90,181
OzempicSemaglutide68$88,077
TrulicityDulaglutide66$86,526
FarxigaDapagliflozin Propanediol70$76,081
JardianceEmpagliflozin36$53,246
MounjaroTirzepatide38$50,517
XareltoRivaroxaban56$39,496
EliquisApixaban38$34,231
LinzessLinaclotide26$25,832
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog32$18,573
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$16,807
SymbicortBudesonide/Formoterol Fumarate57$16,795
Repatha SureclickEvolocumab16$13,775
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog23$13,175
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog33$12,702

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro, Humulin 70-30$117$140,348120 claims
AstraZenecaFarxiga, Symbicort$77$92,875127 claims
MerckJanuvia$158$90,18165 claims
Novo NordiskOzempic$368$88,07768 claims
Boehringer IngelheimJardiance, Pradaxa$376$55,35248 claims
Johnson & JohnsonXarelto$332$39,49656 claims
PfizerEliquis$51$34,23138 claims
AbbVieLinzess, Synthroid$88$27,30345 claims
GSKTrelegy Ellipta, Shingrix$890$19,82330 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Camilla

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →